Rupeestop
Login

Instruments

Mutual Fund
Portfolio Management
Fixed Deposit
Bonds
FD CalculatorNPS CalculatorRD CalculatorCAGR Calculator
NSC CalculatorHRA CalculatorMF CalculatorSSY Calculator
See All Calculators
RupeestopAbout UsMutual Funds

Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 30 Sept 2026. Factsheet Jun 2026. About · Disclosures

Tata India Pharma and Healthcare Fund Regular Plan Growth

Tata Mutual Fund
Sectoral Pharma and HealthcareRegularGrowthRS 72
NAV

₹32.3705

As on 30 Sept 2026

Vs category

PeriodThis fundCategoryRank
1 year+7.91%——
3 year+17.09%——
5 year+12.49%——
Sharpe
0.79
Std dev
16.36%
Beta
0.99

All Sectoral Pharma and Healthcare funds · Tata Mutual Fund

Returns

From NAVs through 30 Sept 2026

1Y
+7.91%
Total
3Y
+17.09%
p.a.
5Y
+12.49%
p.a.
SI
+13.44%
p.a.

Calendar years

-8.04%
2022
+36.58%
2023
+40.40%
2024
-4.92%
2025
+7.16%
2026 YTD

Rolling 1-year · 51 overlapping windows

-11.36%avg +16.51%+60.33%

Fund facts

Fund details from the Jun 2026 factsheet

Fund size
₹1386.99 Cr
Expense ratio
1.84%
Exit load
None
Lock-in
None
Launched28 Dec 2015
StructureOpen Ended
ISININF277K016A9

Where the money is invested

Split by asset type.

By asset type

Equity99.30%
Cash0.70%

What the fund holds

42 holdings · portfolio as on 30 May 2026

  • Sun Pharmaceuticals Industries Ltd
    Healthcare
    9.38%
  • Healthcare Global Enterprises Ltd
    Healthcare
    5.87%
  • Divi's Laboratories Ltd
    Healthcare
    5.8%
  • Abbott India Ltd
    Healthcare
    5.41%
  • Cipla Ltd
    Healthcare
    5.18%
  • Max Healthcare Institute Ltd Ordinary Shares
    Healthcare
    4.8%
  • Apollo Hospitals Enterprise Ltd
    Healthcare
    4.56%
  • Rainbow Childrens Medicare Ltd
    Healthcare
    4.52%
  • Dr Reddy's Laboratories Ltd
    Healthcare
    4.02%
  • Mankind Pharma Ltd
    Healthcare
    3.77%

Concentration

Top 5 weight
31.64%
Top 10 weight
53.31%
Avg turnover
43.33%

Risk and quality measures

How steady the returns have been.

Return quality

Sharpe
0.79
Below category avg 0.98
Sortino
1.1
Return per unit of downside risk
Alpha
-2.48
Return above the benchmark

Risk

Std deviation
16.36%
How much returns swing
Beta
0.99
Below category avg 0.95
R-squared
96.8%
How closely it tracks the benchmark

Who manages this fund

1 fund manager

  • RS
    Rajat Srivastava
    1.4 years in the industry
    Runs 1 scheme

Other Sectoral Pharma and Healthcare funds

SIP illustration

Rate
+17.09%
Invested
₹6,00,000
Illustrated
₹15,86,855

₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator

Other versions

FAQ

What is Tata India Pharma and Healthcare Fund Regular Plan Growth NAV today?

The latest NAV of Tata India Pharma and Healthcare Fund Regular Plan Growth is ₹32.3705 as on 30 Sept 2026.

How has Tata India Pharma and Healthcare Fund Regular Plan Growth performed vs its category?

1-year return +7.91%. Past performance does not guarantee future returns.

What are the returns of Tata India Pharma and Healthcare Fund Regular Plan Growth?

Trailing returns from published NAVs: 1 year +7.91%, 3 year +17.09% a year, 5 year +12.49% a year, since our first NAV +13.44% a year. Past performance does not guarantee future returns.

How would a SIP in Tata India Pharma and Healthcare Fund Regular Plan Growth have been illustrated?

The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +17.09%. It is not a forecast.

What is the expense ratio and fund size of Tata India Pharma and Healthcare Fund Regular Plan Growth?

For Tata India Pharma and Healthcare Fund Regular Plan Growth, the expense ratio is 1.84% and fund size (AUM) is ₹1386.99 Cr.

What is the ISIN of Tata India Pharma and Healthcare Fund Regular Plan Growth?

The ISIN for Tata India Pharma and Healthcare Fund Regular Plan Growth is INF277K016A9.

Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.

Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.